Live Oak Investment Partners Purchases New Position in Cigna Group $CI

Live Oak Investment Partners acquired a new position in Cigna Group (NYSE:CIFree Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 2,773 shares of the health services provider’s stock, valued at approximately $764,000.

Several other institutional investors also recently bought and sold shares of the company. Assetmark Inc. raised its position in shares of Cigna Group by 10.0% in the 1st quarter. Assetmark Inc. now owns 65,662 shares of the health services provider’s stock worth $17,515,000 after acquiring an additional 5,963 shares in the last quarter. HighTower Advisors LLC lifted its stake in shares of Cigna Group by 402.7% during the 2nd quarter. HighTower Advisors LLC now owns 354,398 shares of the health services provider’s stock worth $97,701,000 after purchasing an additional 283,897 shares during the last quarter. Victory Capital Management Inc. boosted its position in Cigna Group by 41.1% during the fourth quarter. Victory Capital Management Inc. now owns 1,348,713 shares of the health services provider’s stock valued at $371,206,000 after purchasing an additional 392,978 shares in the last quarter. Handelsbanken Fonder AB boosted its position in Cigna Group by 12.1% during the second quarter. Handelsbanken Fonder AB now owns 82,825 shares of the health services provider’s stock valued at $22,833,000 after purchasing an additional 8,960 shares in the last quarter. Finally, TD Asset Management Inc grew its stake in Cigna Group by 4.8% in the second quarter. TD Asset Management Inc now owns 249,966 shares of the health services provider’s stock valued at $68,911,000 after purchasing an additional 11,471 shares during the last quarter. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, insider Nicole S. Jones sold 19,436 shares of the firm’s stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total value of $5,369,583.72. Following the completion of the transaction, the insider owned 27,256 shares in the company, valued at $7,530,015.12. This trade represents a 41.63% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This represents a 27.52% decrease in their position. The SEC filing for this sale provides additional information. 0.60% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the stock. Piper Sandler reduced their target price on shares of Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a report on Wednesday, June 3rd. UBS Group raised their price target on shares of Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a report on Friday, May 22nd. Morgan Stanley lifted their price objective on shares of Cigna Group from $355.00 to $361.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 20th. Mizuho boosted their price objective on shares of Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a research note on Monday, June 8th. Finally, Wall Street Zen cut shares of Cigna Group from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. Fifteen investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $339.45.

Check Out Our Latest Research Report on CI

Cigna Group Stock Performance

Shares of Cigna Group stock opened at $277.36 on Thursday. The company has a 50 day moving average price of $285.03 and a 200 day moving average price of $281.41. The firm has a market capitalization of $73.29 billion, a P/E ratio of 11.48, a PEG ratio of 0.96 and a beta of 0.29. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. Cigna Group has a 52 week low of $239.51 and a 52 week high of $315.47.

Cigna Group (NYSE:CIGet Free Report) last released its earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The company had revenue of $70.04 billion for the quarter, compared to the consensus estimate of $70.14 billion. During the same quarter in the previous year, the firm earned $7.20 EPS. Cigna Group’s revenue was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Sell-side analysts expect that Cigna Group will post 30.51 EPS for the current year.

Cigna Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be paid a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date is Tuesday, September 8th. Cigna Group’s payout ratio is presently 25.82%.

About Cigna Group

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Featured Stories

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.